| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/23/2014 | WO2013188763A9 Compositions for treating cancer and methods for making the same |
| 01/23/2014 | WO2013181597A3 Thiol-ene click chemistry for drug conjugates |
| 01/23/2014 | WO2013173410A3 Affinity peptides toward infliximab |
| 01/23/2014 | WO2013168177A3 Osmotically controlled drug delivery systems |
| 01/23/2014 | WO2013167112A8 Composition for nasal application |
| 01/23/2014 | WO2013140317A3 Peptides |
| 01/23/2014 | US20140024808 Factor viii polymer conjugates |
| 01/23/2014 | US20140024776 High molecular weight zwitterion-containing polymers |
| 01/23/2014 | US20140024723 Composition comprising an organic liquid diluent and a specific hydroxypropyl methylcellulose |
| 01/23/2014 | US20140024722 Nanostructured Physically-Associating Hydrogels for Injectable, Responsive, and Tough Biomaterials |
| 01/23/2014 | US20140024718 Controlled release formulations of levodopa and uses thereof |
| 01/23/2014 | US20140024703 Novel Block Copolymer, Micelle Preparation, And Anticancer Agent Containing The Same As Active Ingredient |
| 01/23/2014 | US20140024691 Formulations of bendamustine |
| 01/23/2014 | US20140024633 Orally administrable gallium compositions and methods of use |
| 01/23/2014 | US20140024631 Steroids as Agonists for FXR |
| 01/23/2014 | US20140024604 Glycopeptide phosphonate derivatives |
| 01/23/2014 | US20140024602 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| 01/23/2014 | US20140024582 Stable insulin formulations and methods of making and using thereof |
| 01/23/2014 | US20140023718 Prostaglandin-containing fat emulsion |
| 01/23/2014 | US20140023717 Methods and compositions for treating proliferative diseases |
| 01/23/2014 | US20140023715 Polymer conjugates targeting cells and methods related thereto |
| 01/23/2014 | US20140023714 Hemostatic compositions |
| 01/23/2014 | US20140023712 Aqueous Transparent Oil-In-Water Emulsion Comprising an Emulsified Carotenoid |
| 01/23/2014 | US20140023709 Oral tablet compositions of dexlansoprazole |
| 01/23/2014 | US20140023707 Co-Processed Carbohydrate System as a Quick-Dissolve Matrix for Solid Dosage Forms |
| 01/23/2014 | US20140023705 Dosage forms for oral administration and methods of treatment using the same |
| 01/23/2014 | US20140023700 Cyclic peptide and conjugate thereof for binding to keratinocytes |
| 01/23/2014 | US20140023698 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents |
| 01/23/2014 | US20140023688 Encapsulated oils |
| 01/23/2014 | US20140023666 Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof |
| 01/23/2014 | US20140023665 Novel maytansinoid derivatives with sulfoxide linker |
| 01/23/2014 | US20140023662 Non-antagonistic egfr-binding molecules and immunoconjugates thereof |
| 01/23/2014 | US20140023655 Formulations with reduced viscosity |
| 01/23/2014 | US20140023632 Pharmaceutical formulation |
| 01/23/2014 | US20140023629 Ameliorating agent for chronic obstructive pulmonary disease |
| 01/23/2014 | US20140023624 Decellularized liver transplantation composition and methods |
| 01/23/2014 | US20140023617 Method for treating ifnalpha related conditions |
| 01/23/2014 | US20140023615 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
| 01/23/2014 | US20140023591 Heteromultivalent nanoparticle compositions |
| 01/23/2014 | CA2875351A1 Injectable antibiotic formulations and their methods of use |
| 01/22/2014 | EP2687233A1 Binder for tablet forming |
| 01/22/2014 | EP2687231A1 Composition for treatment and diagnosis of pancreatic cancer |
| 01/22/2014 | EP2687207A1 System for delivering biologically active agents into an organism and method for producing said system |
| 01/22/2014 | EP2687204A1 Vector for pulmonary delivery, inducing agent, and uses |
| 01/22/2014 | EP2687203A1 Emulsified composition for dilution and cancer vaccine composition |
| 01/22/2014 | EP2687202A1 Subcutaneous anti-her2 antibody formulation |
| 01/22/2014 | EP2686342A2 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use |
| 01/22/2014 | EP2686020A1 Re-directed immunotherapy |
| 01/22/2014 | EP2686019A1 New conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanionic polypeptide for the treatment of aids |
| 01/22/2014 | EP2686018A2 Polymer hydrogels for in vivo applications and methods for using and preparing same |
| 01/22/2014 | EP2686017A1 An ophthalmic composition |
| 01/22/2014 | EP2686009A1 Method for preparing multiple antigen glycopeptide carbohydrate conjugates |
| 01/22/2014 | EP2685992A1 Amino-quinolines as kinase inhibitors |
| 01/22/2014 | EP2685969A2 Use of intracellular enzymes for the release of covalently linked bioactives |
| 01/22/2014 | EP2685963A2 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control |
| 01/22/2014 | EP2685962A1 Topical nitric oxide systems and methods of use thereof |
| 01/22/2014 | EP2412744B1 Method for preparing branched functionalised polymers using branched polyol cores |
| 01/22/2014 | CN1852687B Method for the preparation of controlled release formulations |
| 01/22/2014 | CN103533962A 一种眼用组合物 An ophthalmic composition |
| 01/22/2014 | CN103533959A Formulation for anti-Alpha4Beta7 antibody |
| 01/22/2014 | CN103533936A Liposome containing pyrroloquinoline quinone and sugar |
| 01/22/2014 | CN103533935A Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses |
| 01/22/2014 | CN103533927A Compositions for percutaneous administration of physiologically active agents |
| 01/22/2014 | CN103533922A Antigenic formulation |
| 01/22/2014 | CN103533920A Film-shaped externally used drug composition |
| 01/22/2014 | CN103528474A Detection method for vaginal expansion plug |
| 01/22/2014 | CN103524795A Thermo-sensitive type injectable chitosan hydrogel product and applications thereof |
| 01/22/2014 | CN103524764A Preparation method of isolated soy protein macromolecular interpenetrating network hydrogel and application of hydrogel serving as medicine controlled release carrier |
| 01/22/2014 | CN103524761A Medical devices based on cellulose |
| 01/22/2014 | CN103524760A Deoxycholic group-oxidized curdlan polysaccharide nanoparticle and preparation method thereof |
| 01/22/2014 | CN103524759A Method for preparing animal keratin base macromolecular hydrogel and application of hydrogel serving as medicine carrier |
| 01/22/2014 | CN103524756A Preparation method of light/pH (potential of hydrogen) sensitive type pyrene functional polymer micelle |
| 01/22/2014 | CN103524750A Polyethylene glycol chitosan self-assembled nanoparticles and preparation method thereof |
| 01/22/2014 | CN103524748A Polyamino acid graft copolymer, preparation method thereof and injectable hydrogel |
| 01/22/2014 | CN103524687A Photosensitive degradable comb-like copolymer film with controllable surface appearance and performance |
| 01/22/2014 | CN103524639A Synthesis method and application of chitosan oligosaccharide/indometacin graft |
| 01/22/2014 | CN103524628A Recombinant ganoderma lucidum immunoregulatory protein, human serum albumin fusion protein, and preparation method and application thereof |
| 01/22/2014 | CN103524519A Camptothecin prodrug monomer and polymeric prodrug amphipathic molecules thereof as well as preparation method and application of camptothecin prodrug monomer and polymeric prodrug amphipathic molecules |
| 01/22/2014 | CN103520739A Self-assembly compound system of cellulose nanometer fibril and indometacin and preparation method of self-assembly compound system |
| 01/22/2014 | CN103520738A Carbon nano tube loaded antiviral medicine compound as well as preparation method and application thereof in production of aquaculture virus-free carrying fry |
| 01/22/2014 | CN103520737A Carbon nano tube carrier vaccination-free vaccine as well as preparation method and application thereof in preparation of aquatic immune offspring seed |
| 01/22/2014 | CN103520736A Floxuridine-layered double hydroxide nanohybrid with polyethylene glycol derivative modified on surface and preparation thereof |
| 01/22/2014 | CN103520735A Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 01/22/2014 | CN103520734A Albumin-based nano particle and preparation method and application thereof |
| 01/22/2014 | CN103520733A Coating agent capable of overcoming solution sedimentation |
| 01/22/2014 | CN103520732A Azelnidipine preparation with combination of two disintegrating agents and preparation method of azelnidipine preparation |
| 01/22/2014 | CN103520731A Folate-polyethylene glycol-polylactic acid segmented copolymer micelle encapsulated with hydrophobic anticancer drug and preparation method of segmented copolymer micelle |
| 01/22/2014 | CN103520730A Chitosan oligosaccharide nanoparticle capable of loading hydrophobic anti-tumor medicine |
| 01/22/2014 | CN103520729A Toughening forming auxiliary for preparing hard capsule taking starch as matrix and application |
| 01/22/2014 | CN103520728A Preparation method of arsenic trioxide invisible immunological targeting antitumor preparation |
| 01/22/2014 | CN103520727A Capsule shell and preparation method thereof |
| 01/22/2014 | CN103520726A Preparation method of invisible thermosensitive liposome as well as application of drug delivery system of invisible thermosensitive liposome in tumor treatment drugs |
| 01/22/2014 | CN103520720A Preparation method of folic acid coupled carboxymethyl chitosan nanoparticle serving as photo-releasing NO carrier |
| 01/22/2014 | CN103520708A Composition capable of promoting wound healing and reducing scarring |
| 01/22/2014 | CN103520707A Probiotic and bacteria-treating composition for preventing and treating infection of reproductive system |
| 01/22/2014 | CN103520706A Oral recombined human serum albumin fusion protein preparation formula, products of the protein preparation, and applications of the protein preparation |
| 01/22/2014 | CN103520635A Compound zedoary oil expandable vaginal suppository, and preparation method and detection method thereof |
| 01/22/2014 | CN103520604A Baicao expandable vaginal suppository for clearing gynecologic inflammation, and preparation method and detection method thereof |
| 01/22/2014 | CN103520603A Fuyanling expandable vaginal suppository, and preparation method and detection method thereof |
| 01/22/2014 | CN103520551A Damp heat constitution type health-care food and preparation method thereof |